Camera showdown: which machine best sees heart failure damage?
NCT ID NCT02515812
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested two types of cameras—a newer CZT camera and a standard Anger camera—to see how well they measure heart nerve function in people with heart failure. Forty-five patients received a special tracer injection (I-123-MIBG) and were scanned with both cameras. The goal was to validate whether the newer camera gives equally reliable results, which could help doctors better assess heart failure severity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
I-123-MIBG
What this could lead to
If successful, this could help doctors choose the best camera for evaluating heart failure patients, potentially improving risk assessment.
What could go wrong
This is a small, completed imaging comparison study, not a treatment trial. It does not test any new therapy or directly improve patient outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Médecine Nucléaire -CHU de Caen
Caen, 14000, France